FR2152507B1 - - Google Patents

Info

Publication number
FR2152507B1
FR2152507B1 FR7206562A FR7206562A FR2152507B1 FR 2152507 B1 FR2152507 B1 FR 2152507B1 FR 7206562 A FR7206562 A FR 7206562A FR 7206562 A FR7206562 A FR 7206562A FR 2152507 B1 FR2152507 B1 FR 2152507B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7206562A
Other languages
French (fr)
Other versions
FR2152507A1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2152507A1 publication Critical patent/FR2152507A1/fr
Application granted granted Critical
Publication of FR2152507B1 publication Critical patent/FR2152507B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7206562A 1971-09-10 1972-02-25 Expired FR2152507B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1329871A CH563405A5 (enExample) 1971-09-10 1971-09-10

Publications (2)

Publication Number Publication Date
FR2152507A1 FR2152507A1 (enExample) 1973-04-27
FR2152507B1 true FR2152507B1 (enExample) 1975-04-25

Family

ID=4391173

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7206562A Expired FR2152507B1 (enExample) 1971-09-10 1972-02-25

Country Status (11)

Country Link
US (1) US3832341A (enExample)
JP (1) JPS4834195A (enExample)
BE (1) BE785575A (enExample)
CA (1) CA972747A (enExample)
CH (1) CH563405A5 (enExample)
DE (1) DE2160104A1 (enExample)
DK (1) DK130685B (enExample)
FR (1) FR2152507B1 (enExample)
GB (1) GB1317075A (enExample)
NL (1) NL7200191A (enExample)
SE (1) SE399268B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2226295A1 (de) * 1972-05-30 1973-12-20 Henning Berlin Gmbh Salpetersaeureester von purinnucleosiden und verfahren zur herstellung derselben
US4104462A (en) * 1975-02-18 1978-08-01 Hoffmann-La Roche Inc. Cardioactive adenosine nitrates
US4122172A (en) * 1975-03-18 1978-10-24 Byk Gulden Lomberg Chemische Fabrik Gmbh β-D-1-(6-amino-9H-purin-9-yl)-1-deoxy-2,3-di-O-nitroribofuranuronethylamide
AT350735B (de) * 1976-08-06 1979-06-11 Hoffmann La Roche Verfahren zur herstellung von neuen ribo- furanosyl-imidazolderivaten
JPS53123993A (en) * 1977-04-04 1978-10-28 Horiba Ltd Water sampler for water quality measuring apparatus
EP0004261B1 (de) * 1978-02-01 1982-04-28 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Neue Imidazolderivate, Verfahren zu deren Herstellung und Arzneimittel diese enthaltend
JPS5767190U (enExample) * 1980-10-08 1982-04-22
CN103087133B (zh) * 2004-05-26 2016-09-14 伊诺泰克制药公司 嘌呤衍生物作为腺苷a1受体激动剂及其用法
NZ554506A (en) * 2004-09-20 2011-01-28 Inotek Pharmaceuticals Corp Purine derivatives and methods of use thereof
DE102005043031A1 (de) * 2005-09-10 2007-03-15 Mauer, Dieter, Dr. Verfahren zum Entfernen von Phosphaten aus Acetat-gepufferten Lösungen
EP1962597A4 (en) * 2005-11-30 2008-12-17 Inotek Pharmaceuticals Corp PURINE DERIVATIVES AND METHOD OF USE
AU2011203897B2 (en) 2010-01-11 2016-11-17 Inotek Pharmaceuticals Corporation Combination, kit and method of reducing intraocular pressure
BR112012023749A2 (pt) 2010-03-26 2016-08-23 Inotek Pharmaceuticals Corp método para reduzir a pressão intraocular em humanos utilizando n6-ciclopentiladenosina (cpa), derivados de cpa ou pró-fármacos desses
AP2014007796A0 (en) 2011-12-22 2014-07-31 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
BR112014018413A8 (pt) 2012-01-26 2017-07-11 Inotek Pharmaceuticals Corp Polimorfos anidros de nitrato de metila [(2r,3s,4r,5r)-5-(6-(ciclopentilamino)-9h-purin-9-il)-3,4-diidroxitetraidrofuran-2-il)] e processos de preparação do mesmo
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
EA201591433A1 (ru) 2013-03-15 2015-12-30 Инотек Фармасьютикалс Корпорейшн Офтальмологические составы
EP2876166B1 (en) 2013-11-20 2016-12-14 Roche Diagnostics GmbH New compound for sequencing by synthesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595853A (en) * 1968-03-19 1971-07-27 Kohjin Co Ribofuranosyl cytosine and arabinofuranosyl cytosine derivatives

Also Published As

Publication number Publication date
NL7200191A (enExample) 1973-03-13
CH563405A5 (enExample) 1975-06-30
BE785575A (fr) 1972-12-29
JPS4834195A (enExample) 1973-05-16
US3832341A (en) 1974-08-27
DE2160104A1 (de) 1973-03-22
FR2152507A1 (enExample) 1973-04-27
SE399268B (sv) 1978-02-06
DK130685B (da) 1975-03-24
GB1317075A (en) 1973-05-16
DK130685C (enExample) 1975-09-08
CA972747A (en) 1975-08-12

Similar Documents

Publication Publication Date Title
ATA136472A (enExample)
AR196074A1 (enExample)
AU2658571A (enExample)
AU2691671A (enExample)
AU2952271A (enExample)
AU2941471A (enExample)
AU2894671A (enExample)
AU2742671A (enExample)
AU2726271A (enExample)
AU2485671A (enExample)
AU3005371A (enExample)
AU2684071A (enExample)
AU2564071A (enExample)
AU2473671A (enExample)
AU2836771A (enExample)
AU3038671A (enExample)
AU2503871A (enExample)
AR192311Q (enExample)
AU2577671A (enExample)
AU2588771A (enExample)
AU2654071A (enExample)
AU2963771A (enExample)
AU2669471A (enExample)
AU2456871A (enExample)
AU2684171A (enExample)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse